NEW YORK (GenomeWeb) – The Garvan Institute of Medical Research has selected DNAnexus' platform to support ongoing genomics-based research initiatives and will use the system to support a planned commercial genome sequencing service.
According to DNAnexus, its platform provides the Garvan Institute with tools to process, manage, analyze, and share large quantities of sequence data. Garvan's Kinghorn Centre for Clinical Genomics (KCCG) has the capability to sequence 150 whole human genomes every three days, which amounts to 18,000 sequences annually. Using the DNAnexus platform, the Institute is able to meet its analysis needs without having to take on the time and costs of building out their local infrastructure.
"With the help of the DNAnexus platform, we have deployed a service that capitalizes on lower costs of whole-genome sequencing," Marcel Dinger, head of KCCG, said in a statement. "We want to make that data available and actionable worldwide, whether in a research, commercial, or clinical setting."